Summary of HR 5239: Endometrial Cancer Research and Education Act of 2025

Purpose and Intent

The Endometrial Cancer Research and Education Act of 2025 aims to enhance the understanding, prevention, and treatment of endometrial cancer, which is a significant health concern affecting many women in the United States. The bill seeks to allocate resources for research initiatives and educational programs to improve awareness and outcomes related to this type of cancer.

Key Provisions

While the specific text of the bill is not provided, based on its title and intent, the following key provisions can be anticipated:

• Research Funding: The bill is likely to propose funding for research projects focused on endometrial cancer, including studies on its causes, risk factors, and potential treatment options.

• Educational Initiatives: It may include provisions for public education campaigns aimed at increasing awareness about endometrial cancer symptoms, risk factors, and the importance of early detection.

• Collaboration with Health Organizations: The bill might encourage partnerships between federal health agencies, academic institutions, and non-profit organizations to foster comprehensive research and education efforts.

• Data Collection and Analysis: There may be a focus on improving data collection related to endometrial cancer incidence and outcomes to better inform future research and policy decisions.

Who Would Be Affected

The following groups are expected to be impacted by the provisions of HR 5239:

• Patients and Survivors: Women diagnosed with endometrial cancer and those at risk would benefit from improved research and educational resources.

• Healthcare Providers: Medical professionals would gain access to updated information and guidelines regarding endometrial cancer diagnosis and treatment.

• Researchers: Scientists and academic institutions engaged in cancer research would receive funding and support for their work on endometrial cancer.

• Public Health Organizations: Non-profits and advocacy groups focused on women's health would have opportunities to collaborate on educational initiatives.

Legislative Process and Timeline

• Introduced: The bill was introduced in the House on September 9, 2025.
• Referred to Committee: On the same day, it was referred to the House Committee on Energy and Commerce for further consideration.

Sponsors

The bill is sponsored by David Scott, with several cosponsors including:
- Gwen Moore
- Paul Tonko
- Henry C. "Hank" Johnson
- Eleanor Holmes Norton
- Yvette D. Clarke
- Shontel M. Brown
- Terri A. Sewell

These sponsors reflect a bipartisan effort to address the critical issue of endometrial cancer through legislative action.

Conclusion

HR 5239 represents a proactive approach to tackling endometrial cancer through dedicated research and education. By enhancing awareness and understanding of this disease, the bill aims to improve health outcomes for women affected by endometrial cancer across the nation. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and funding allocations.